HotSheets 2013
- FDA Expands Zytiga’s Use for Late-Stage CRPC Prior to Chemotherapy
- Adding Testosterone to Sildenafil Does Not Benefit Men with Erectile Dysfunction
- Aerobic Exercise Eases Fatigue in Patients with Breast and Prostate Cancer
- Diagnostic Performance of PCA3 for Detecting Prostate Cancer in Men with an Elevated PSA
- Phase II Study of Cabozantinib in Men with Advanced Prostate Cancer
- Doc Moyad’s “No Bogus Science” Column – “What Has 150 Calories & Stifles Weight
- Ask Doctor Snuffy Myers
- Doctor Chodak’s Bottom Line
- Index of Articles Published in 2012 HotSheets
- Protons for Prostate Cancer: Fleeting Quality of-Life Benefits
- Updated Partin Tables Now Available
- Radium-223 New Drug Application Submitted
- Cost of Prostate Cancer Treatments Compared
- Do Genetic Markers Improve Prostate Cancer Risk Prediction After an Initial Negative Biopsy?
- Targeted Prostate Biopsy May Improve Care
- 2-Weekly Vs. 3-Weekly Docetaxel
- Association of Adiponectin & Leptin with Stage & Grade of PSA-Detected Prostate Cancer
- Be Prepared, by Ray Marsh, Us TOO, UK
- Antioxidants – the Enemy in Cancer Treatment?
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – “Is It Time to Discuss Metformin with Your MD?”
- Doctor Chodak’s Bottom Line
- Similar Function after Surgery & Radiation
- ‘Smarter’ PSA Testing Strategies Proposed
- REDUCE Study & Rates of Prostate Cancer
- 10-Year Oncologic Outcomes after Low Dose Rate Brachytherapy for Prostate Cancer
- Low Neutrophil Count & Prostate Biopsies
- Regaining Continence After Prostate Surgery
- Identification Errors in Prostate Biopsies
- Prostatectomy Outcomes in Low-Risk Cancer
- T2–Diffusion-Weighted MRI & Adverse Post-prostatectomy Pathologic Outcome
- High Fiber Diet & Prostate Cancer Progression
- Ask Doctor Snuffy Myers
- Doc Moyad’s “No Bogus Science” Column – “Exercise & Statins & Prostate Cancer Death”
- Shorter ADT Duration Ok in High-Risk Cancer
- Prostate Cancer Overtreatment Costs $32M
- Updated Survival Benefits with Abiraterone
- Prostate Health Index vs. PCA-3 Urine Test
- 25-Year Survival Rate After Irradiation
- Identifying Prostate Cancer by Changes in PSA
- Male-Pattern Baldness & Prostate Cancer Risk
- Doc Moyad’s “No Bogus Science” Column – “More About Mediterranean Diets”
- Ask Doctor Snuffy Myers
- Clues Found to Prostate Cancer Upgrading
- Long-Term RT Outcomes in Men Under 60
- Dasatinib Fails in Phase III CRPC Trial
- Doctor Chodak’s Bottom Line
- Intermittent Hormone Treatment for Prostate Cancer Not the Best
- Additional Role for Abiraterone in CRPC
- Degarelix Showing Promise in Prostate Cancer
- Long-Term PSA Velocity in Improved Classifi-cation of Prostate Cancer Risk & Mortality
- Benign Glandular Tissue at Radica
- Prostatectomy Surgical Margins
- Doc Moyad’s “No Bogus Science” Column – “End of the Line for High-Dose Selenium”
- Richard Petty Teams Up With Janssen Biotech to Launch “Show Your Stripes for Prostate Cancer Awareness”
- Congressionally Directed Medical Research Programs Research Funding for 2013
- Doctor Chodak’s Bottom Line
- AUA & ASTRO Issue Joint Guideline for Postsurgery Radiotherapy
- New AUA Guideline for Castrate-Resistant Prostate Cancer
- AUA Issues New Guidelines on PSA Screening
- Cancer Immunotherapy: An Overview
- Doc Moyad’s “No Bogus Science” Column – “Former Smokers – Beware of Beta-carotene”
- High-Dose Radiotherapy: Better Local Con-trol, Not Survival
- Gene Test For Prostate Cancer Shows Promise
- Midlife PSA Test Predicts Future Prostate Cancer Risk
- Doctor Chodak’s Bottom Line
- Xofigo (Radium-223) Approved for Prostate Cancer with Bone Metastases
- Prostate Cancer with Faulty BRCA2 Gene Spreads More Quickly
- How Likely Is Prostate Cancer To Kill?
- Itraconazole vs. Advanced Prostate Cancer
- Can A Gene Test Predict Prostate Cancer?
- Doc Moyad’s “No Bogus Science” Column – “Vitamin C Can Cause Kidney Stones”
- New AUA Guidelines on PSA Screening
- Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
- June is Men’s Health Month
- Enzalutamide in Advanced, Hormone Naïve Prostate Cancer Reduces PSA
- Doctor Chodak’s Bottom Line
- Active Surveillance May Miss Aggressive Prostate Cancers in Black Men
- Advanced Treatment Technologies for Men with Low Risk Prostate Cancer
- Observation – Better Efficacy, Cost, QoL
- Cross-resistance with Novel Androgen Blockers in Prostate Cancer
- Doc Moyad’s “No Bogus Science” Column – Fish Oil Flops in 2012-2013 Research”
- Heart-Healthy Diet May be Healthy for Prostate Cancer
- Brisdelle Okayed as First Nonhormonal Treatment for Hot Flashes
- Expanding Active Surveillance Criteria
- 5-alpha Reductase Inhibitors for LUTS and Prevention of Prostate Cancer
- Doctor Chodak’s Bottom Line
- Metformin & Prostate Cancer Mortality
- Stop Calling Low-Risk Lesions Cancer
- Ketoconazole & Fatal Liver Toxicity
- Taxotere + 153Samarium for CRPC
- Defining A Castrate Testosterone Level
- Endurance Training for ADT-Weight Gain
- Doc Moyad's "No Bogus Science" Column – "Obesity Deaths Have Been Underestimated"
- GAO Targets Self-Referrals for RT
- Risk of Kidney Injury from ADT?
- Soy Fails to Slow PSA Rise after RP
- Doctor Chodak's Bottom Line
- Insurers Nix Payment for Proton Beam Radiation Treatment for Prostate Cancer
- Chemoprevention for Prostate Cancer
- Low-Grade Prostate Cancers Don’t Worsen
- Testosterone Therapy Does Not Raise Prostate Cancer Recurrence Risk
- Effect of Repeated Prostate Biopsies on Erectile Function During Active Surveillance
- Mortality in Men Treated by RP, EBRT and BT Mortality without Comorbid Illness
- American Cancer Society Ends Man-2-Man
- 15th Annual Us TOO Walk & Run
- Doc Moyad’s “No Bogus Science” Column – “Resveratrol is a Waste of Money”
- Laparoscopic Prostatectomy in Obese Men
- Doctor Chodak’s Bottom Line
- Fewer Weeks of Hormone Therapy before Radiation Reduces Side Effects
- PSA Screening Does More Harm than Good
- Drugs for Female Hot Flashes Don’t Help Men
- Herbal Products Often Contain Contaminants
- CRPC Responds to Abiraterone Withdrawal
- Disability Benefits and Prostate Cancer
- Commercial Urine Test for Prostate Cancer Available from University of Michigan Labs
- 30-Year Outcomes for Men with Positive Lymph Nodes at Radical Prostatectomy
- Doc Moyad’s “No Bogus Science” Column – “Abiraterone, Prednisone and Potassium”
- The Melbourne Consensus Statement Clarifies the Confusion around PSA Screening
- Enzalutamide Meets Study Endpoints of Overall and Metastatic Progression-Free Survival
- Prostate Cancer Tops in Inheritable Cancers
- Ways to Boost Enrollment in Clinical Trials
- Elastography-Targeted Prostate Biopsies
- PSA <1 ng/mL in Men in Their 40’s Associated with a Very Low Risk of Prostate Cancer
- Origins of Lethal Prostate Cancer Traced
- Clinical Benefits of Non-Taxane Chemotherapy for CRPC after Progression on Docetaxel
- Testosterone Treatment Linked to Heart Risks
- Doc Moyad’s “No Bogus Science” Column – “Colored Fruits and Veggies and Health”